Pregnancy based on animal reproduction studies, therapy may cause fetal harm when administered to pregnant women; there are no adequate and well controlled studies of amoxicillin, omeprazole, or rifabutin (used separately or together) in pregnant women; therapy is generally not recommended for use in pregnancy; if therapy administered during pregnancy, advise pregnant women of potential risk. Omeprazole in pregnancy emedicine. Pregnancy based on findings in animal studies for omeprazole and clarithromycin during pregnancy may cause fetal harm; therapy is not recommended for use in pregnant women except in clinical circumstances where no alternative therapy is appropriate; ii therapy is administered during pregnancy, or if pregnancy occurs while receiving therapy, the patient should be apprised of the potential.
omeprazole in pregnancy emedicine
Pregnancy human data aspirin use of nsaids, including aspirin, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus and use of high-dose aspirin for long periods in pregnancy may also increase the risk of bleeding in the brain of premature infants; avoid use beyond 30 weeks of gestation. Pregnancy. there are no adequate and well-controlled studies in pregnant women; advise pregnant women of the potential risk of fetal harm; drug should be used during pregnancy only if potential benefit justifies potential risk to fetus. lactation. pantoprazole and metabolites are excreted in milk of rats.. Lundell l, miettinen p, myrvold he, et al. continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. j am coll surg . 2001 feb. 192(2):172-9; discussion 179-81..
